Market cap
$449m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
Total deferred revenue as of June 30, 2026 and December 31, 2025 for the CSL Collaboration Agreement was $ 5.2 million and $ 6.2 million, respectively. The costs associated with these reimbursements are reflected as a component of research and development expense in the Company’s condensed consolidated statements of operations and comprehensive loss. As of June 30, 2026, the remaining available funding net of revenue e arned was $ 24.6 million. Sales Agreement On December 23, 2022, the Company entered into a Controlled Equity Offering℠ Sales Agreement, which was amended on August 7, 2023 (as amended, the “Sales Agreement”) with Cantor Fitzgerald & Co. …Arcturus Therapeutics Holdings Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06